Back
Inozyme Pharma 10K Form
Sell
46
INZY
Inozyme Pharma
Last Price:
4.46
Seasonality Move:
7.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INZY News And Ratings
See the #1 stock for the next 7 days that we like better than INZY
INZY Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-18.59M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.27 |
| Price / Book: | 1.9 |
Profitability
| EPS (TTM): | -1.39000 |
|---|---|
| Net Income (TTM): | $-71.17M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Inozyme Pharma Earnings Forecast
Key Inozyme Pharma Financial Ratios
- The Interest Expense is -4.68% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 2 years.
Inozyme Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INZY |
| CUSIP: | 45790W |
| Website: | inozyme.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INZY Technical Analysis vs Fundamental Analysis
Sell
46
Inozyme Pharma (INZY)
is a Sell
Is Inozyme Pharma a Buy or a Sell?
-
Inozyme Pharma stock is rated a Sell
The current Inozyme Pharma [INZY] share price is $4.33. The Score for INZY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.